Browse Companies
Discover companies hiring across Latin America
Loading companies...
Discover companies hiring across Latin America
Showing 1 to 15 of 15 companies
Neuralworks Technologies designs next-generation non-invasive brain-computer interfaces.
Thermo Fisher Scientific Inc. is a global leader in serving science, formed in 2006 through the merger of Thermo Electron Corporation and Fisher Scientific International Inc. Headquartered in Waltham, Massachusetts, the company employs over 125,000 people and generates annual revenue exceeding $40 billion. Its mission is to enable customers to create a healthier, cleaner, and safer world through innovative technologies, services, and solutions across various sectors. The company operates through four main segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics and Laboratory Products, and Biopharma Services. It offers a wide range of products, including analytical instruments, reagents, lab equipment, and software for research, diagnostics, and manufacturing. Thermo Fisher serves a diverse customer base, including researchers and organizations in life sciences, healthcare, and environmental protection, supporting advancements in areas such as drug discovery, clinical diagnostics, and food safety.
Bringing non-invasive brain stimulation from the hospital to the home
Baxter International Inc. is a global healthcare company dedicated to medical innovation for nearly a century. Founded in 1931, Baxter began as a manufacturer of intravenous therapy solutions and has since expanded its offerings to include a wide range of medical products and therapies used in hospitals, clinics, and home care settings. The company is headquartered in Glenview, Illinois, and has a strong international presence with operations in multiple countries. Baxter's product portfolio includes acute care solutions like intravenous delivery systems, renal care products such as dialysis treatments, surgical and wound care items, nutritional care solutions, and anesthetics. The company has a history of innovation, introducing several firsts in the industry, including the first artificial kidney system and the first needleless IV access system. Baxter is committed to inclusion and diversity in its operations and actively invests in healthcare innovation through Baxter Ventures.
Blood testing device for early diagnosis of cancer and treatment…
GSK plc (GlaxoSmithKline) is a global biopharmaceutical company dedicated to developing vaccines and specialty medicines. With a history dating back to 1715, it is recognized as the longest continually running British pharmaceutical company. GSK has evolved through numerous mergers and innovations, employing around 70,000 people worldwide. The company focuses on areas such as oncology, respiratory diseases, HIV, and infectious diseases. GSK has a strong legacy in research and development, with significant contributions to antibiotics and treatments for various health conditions. Following a demerger in 2022, GSK has streamlined its operations to concentrate on biopharma research and development, enhancing its capabilities through strategic acquisitions.
Indero, based in Montreal, is a contract research organization (CRO) with a focus on clinical research in dermatology and rheumatology. Founded in 2000 as Innovaderm, the company rebranded in 2025 to reflect its expanded expertise. With over 25 years of experience, Indero operates globally across North America, Europe, Latin America, and Asia-Pacific, providing full-service solutions for biotech and pharmaceutical sponsors. The company offers a range of services, including protocol design, patient recruitment, trial monitoring, and support for studies from proof-of-concept to Phase III. Indero specializes in complex endpoints and interdisciplinary approaches for conditions that overlap between dermatology and rheumatology. It also maintains a dedicated research clinic for in-house studies and invests in research and development to enhance methodologies and publish peer-reviewed work. Indero's therapeutic focus includes treatments for atopic dermatitis, psoriasis, and various inflammatory conditions affecting the musculoskeletal system.
IQVIA Holdings Inc. is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. Formed in 2016 through the merger of Quintiles Transnational and IMS Health, and rebranded in 2017, the company is headquartered in Durham, North Carolina, and employs around 86,000 to 88,000 people across more than 100 countries. IQVIA leverages its proprietary IQVIA Connected Intelligence(TM), which combines healthcare-grade data, AI-powered analytics, and domain expertise to enhance clinical development and improve healthcare outcomes. The company offers a comprehensive suite of services, including advanced analytics, technology solutions, and clinical research services. Its capabilities encompass healthcare market intelligence, AI-driven insights, decentralized clinical trials, and full-service contract research organization (CRO) functions. IQVIA serves a diverse range of clients, from small biopharma firms to large pharmaceutical companies, focusing on addressing modern challenges in healthcare and accelerating medical advancements for better patient outcomes.
Workflows to empower employees to spend while finance stay in control
Merck & Co., Inc. is a prominent American pharmaceutical company founded in 1891 by George Merck in New York City. Originally a subsidiary of the German Merck Group, it became independent after being nationalized by the U.S. government in 1917. Known as MSD (Merck Sharp & Dohme) outside North America, Merck has a rich history of innovation in pharmaceuticals and vaccines. The company develops, manufactures, and markets a wide array of pharmaceutical products and vaccines. Its offerings include treatments for infectious diseases, cancer, diabetes, and cardiovascular conditions, as well as vaccines for various preventable diseases. Merck was the first to commercially sell the smallpox vaccine in the U.S. and has a long-standing commitment to research and development, with significant contributions to medical knowledge, including the widely used *Merck Manual*. Merck serves a diverse customer base, including healthcare providers, hospitals, pharmacies, and governments, focusing on addressing unmet medical needs through its innovative medicines and vaccines.
MSD (Merck Sharp & Dohme), also known as Merck & Co., Inc., is a global pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891, MSD has evolved into a leader in human and animal health, focusing on the discovery, development, and distribution of medicines and vaccines. The company has a rich history, tracing its roots back to the German Merck Group established in 1668, and has made significant contributions to public health over its 130+ years of operation. MSD's product offerings include human pharmaceuticals for various conditions such as cardiovascular diseases, infectious diseases, and oncology. Notable products include the first oral diuretic for hypertension, the first FDA-approved statin for cholesterol, and a range of treatments for HIV and Hepatitis C. The company is also recognized for its vaccines, including those for measles, mumps, and rubella, developed under the leadership of Maurice Hilleman. In addition, MSD has a strong presence in animal health, with a portfolio that has expanded since its initial entry into the market in the 1940s. Through its nonprofit foundation, MSD contributes to global health initiatives, including programs aimed at eliminating river blindness.
NotCo is a Chilean food technology company founded in 2015, focused on creating plant-based alternatives to animal products using artificial intelligence. The company utilizes its proprietary AI platform, Giuseppe, to analyze the molecular structure of animal-based foods and identify plant-based ingredients that replicate their taste and texture. This innovative approach allows for faster and more precise product development. NotCo offers a variety of plant-based products designed for mainstream consumers, including NotMilk, a dairy-free milk alternative, NotBurger, a plant-based burger patty, and other items like NotMayo, NotIceCream, and NotChicken. These products are available in major retail chains such as Whole Foods and Walmart, and are featured in menus at popular foodservice brands like Shake Shack and Starbucks. NotCo has also formed strategic partnerships, including a joint venture with Kraft Heinz and collaboration with McDonald’s, to expand its reach and develop new plant-based offerings.
NSF (National Sanitation Foundation) is a not-for-profit organization dedicated to improving human and planetary health through scientific research on sanitation and public health standards. Founded in 1944 at the University of Michigan, NSF became an independent entity in 1967 and has since grown into a global leader in developing and implementing health and environmental standards. The organization offers testing, certification, and standards development services across various sectors, including food equipment, water systems, wastewater treatment, pools, spas, and drinking water. NSF is known for its rigorous standards, such as NSF/ANSI 60 and 61 for drinking water, which are widely adopted in the U.S. and Canada. Through its testing laboratories and innovative programs, NSF ensures that products comply with strict health and safety protocols, contributing significantly to public health and environmental protection.
Roche is a Swiss multinational healthcare company founded in 1896 in Basel, Switzerland. It is recognized as the world's largest biotech company and the fifth-largest pharmaceutical firm by revenue. Roche is a leader in cancer treatments and has a rich history of innovation, including the mass production of synthetic vitamin C and the development of key oncology drugs like Herceptin, Avastin, and Rituxan. The company focuses on research-driven healthcare, integrating pharmaceuticals and diagnostics to address various medical fields, including oncology, immunology, infectious diseases, and personalized medicine. Roche develops innovative medicines and diagnostic tests, emphasizing prevention, targeted therapies, and curing diseases. It invests significantly in research and development, advancing science in biotech and AI-driven healthcare innovations. With a global presence, Roche continues to serve millions of patients through its comprehensive range of healthcare solutions.
Syneos Health is a fully integrated biopharmaceutical solutions organization formed in 2018 through the merger of INC Research and InVentiv Health. With over 26,000 employees across more than 110 countries, the company focuses on synchronizing clinical development and commercial execution for biopharmaceutical clients. Syneos Health leverages AI and technology to enhance customer success, translating insights into outcomes while addressing the challenges of product lifecycles from preclinical stages to market launch. The company offers comprehensive biopharmaceutical solutions that include clinical development, commercialization, and consulting services. Its expertise spans various therapeutic areas, including oncology, central nervous system, and immunology. Syneos Health Consulting provides advisory services across the drug development lifecycle, supporting portfolio strategy, medical affairs, and risk management. The firm has played a significant role in the development and commercialization of a high percentage of novel drugs, contributing to the approval of numerous FDA and EMA products.